Kibow Biotech Selected to Present at the China Bio Partnering Forum 2010

NEWTOWN SQUARE, Pa., June 22 /PRNewswire/ -- Kibow Biotech, Inc. is pleased to announce that it has been selected as one of the six U.S.-based companies to present at the China Bio Partnering Forum to be held June 23-24, 2010, at Suzhou, China. At this prestigious event, a total of 36 companies from several countries (Australia, Belgium, China, Denmark, France, Germany, Hong Kong, Japan, Netherlands, Singapore, South Korea and United Kingdom) will also be presenting their businesses for a potential partnership in China.  

Kibow Biotech, with headquarters in Newtown Square, Pennsylvania, is the only U.S.-based probiotic dietary supplement biotechnology business invited to this prestigious conference. China Bio 2010 is considered the premier Life Sciences Event of the fast-developing biotechnology business in China. Dr. Natarajan Ranganathan, interim CEO stated, "Kibow Biotech is very excited about this opportunity to present the company's breakthrough product, "Kibow Biotics(R)," which utilizes a patented and proprietary bowel-based enteric technology concept for use in worldwide clinical applications towards maintaining a healthy kidney function. It is our intention to seek Chinese business collaborators to make Kibow Biotics(R) available to a wider audience, which currently is only available in USA and Canada via their website. Through collaboration, Kibow Biotech will increase its presence worldwide - more so in China."

For more information, visit: http://www.kibow.com

About Kibow Biotech

Kibow Biotech Inc. is a 12-year-old R&D biotechnology company having its operations in Newtown Square, PA, USA. The company's mission is dedicated to finding a simple, convenient and cost-effective worldwide solution for people experiencing kidney function problems. The company's flagship product is called "Kibow Biotics(R)": an orally consumable, enteric-coated Gel Cap product formulation that is composed of food-grade microbes ("Probiotics") which metabolize the uremic toxins diffusing into the bowel as a consequence of increased levels of these toxins in the blood. The purpose of this non-drug, dietary supplement product is to help maintain a healthy kidney function for people in need of alternative or complementary Over The Counter (OTC) products.

Forward-looking statements

Kibow Biotics(R) or any other dietary supplement is not intended to diagnose, treat, cure or prevent any disease as per the U.S. FDA. Kibow's website contains both historical information and also contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are not guarantees of future performance. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks, uncertainties and other factors that may cause the actual results or performance of the Company to be materially different from such statements or from any future results or performance implied thereby. Factors which could cause the Company's results or performance to differ from current expectations include, but are not limited to, the ability to comply with regulatory requirements applicable to the manufacture and marketing of the Company's products; the Company's ability to obtain and enforce effective patents; the non-infringement of third party patents or proprietary rights by the Company and its products; and the establishment and maintenance of strategic collaborative and commercial relationships. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.    

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.

SOURCE Kibow Biotech, Inc.